Astria Therapeutics, Inc.

ATXSDelisted Jan 23, 2026

Industry: Pharmaceutical Preparations
SEC CIK: 0001454789

SEC filings (opens in a new tab)

Astria Therapeutics, Inc. was delisted on Jan 23, 2026; its insiders filed their last Form 4 on Jan 23, 2026; 141 institutions reported holding it in 13F filings for Q4 2025, worth $738.2M in total; Soros Fund Management was the only superinvestor holding it.

Q4 2024 vs. Q3 2024

How the institutions holding Astria Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of ATXS: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	103	1	111	+9
Shares	56.5M	80.3K	58.5M	+2.11M (+3.7%)
Value	$622.1M	$730.9K	$523.4M	−$98.0M (−15.8%)

1 institution that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (26)

Institutions that held Astria Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to ATXS in Q4 2024
Institution	Shares	Value	% of portfolio
FCPM III Services B.V.	2,872,537	$25.7M	4.34%
Raymond James Financial Inc	79,044	$706.7K	0.00%
Alps Advisors Inc	45,630	$407.9K	0.00%
Connor, Clark & Lunn Investment Management Ltd.	22,160	$198.1K	0.00%
Janus Henderson Group PLC	17,700	$158.5K	0.00%
ProShare Advisors LLC	15,706	$140.4K	0.00%
Cubist Systematic Strategies, LLC	15,278	$136.6K	0.00%
Engineers Gate Manager LP	12,069	$107.9K	0.00%
China Universal Asset Management Co., Ltd.	11,966	$107.0K	0.01%
Teacher Retirement System of Texas	10,125	$91.0K	0.00%
Police & Firemen's Retirement System of New Jersey	10,075	$90.1K	0.00%
Zurcher Kantonalbank (Zurich Cantonalbank)	9,249	$82.7K	0.00%
Virtus ETF Advisers LLC	7,247	$64.8K	0.03%
BNP Paribas Arbitrage, SA	5,572	$49.8K	0.00%
KLP Kapitalforvaltning AS	4,600	$41.1K	0.00%
Mirae Asset Global Investments Co., Ltd.	1,881	$17.2K	0.00%
GF Fund Management Co. Ltd.	1,185	$10.6K	0.00%
Skopos Labs, Inc.	737	$6.59K	0.00%
Daiwa Securities Group Inc.	186	$2.00K	0.00%
Creative Planning	97	$867	0.00%
SRS Capital Advisors, Inc.	65	$582	0.00%
Caitong International Asset Management Co., Ltd	55	$492	0.00%
IFP Advisors, Inc	0	$170	0.00%
The PNC Financial Services Group, Inc.	10	$89	0.00%
Macquarie Group Ltd	4,658	$42	0.00%
SBI Securities Co., Ltd.	1	$9	0.00%

Sold out (17)

Institutions that held Astria Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of ATXS in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Affinity Asset Advisors, LLC	725,106	$7.98M
Sofinnova Investments, Inc.	85,640	$942.9K
Schonfeld Strategic Advisors LLC	79,205	$872.0K
StemPoint Capital LP	56,287	$618.9K
Renaissance Technologies LLC	38,061	$419.1K
Bridgeway Capital Management, LLC	30,101	$331.4K
Qube Research & Technologies Ltd	29,414	$323.8K
Corton Capital Inc.	20,492	$225.6K
Verition Fund Management LLC	18,918	$208.3K
Deerfield Management Company, L.P. (Series C)	12,153	$133.8K
STRS Ohio	11,200	$123.3K
Profund Advisors LLC	11,038	$121.5K
Graham Capital Management, L.P.	10,649	$117.2K
Y-Intercept (Hong Kong) Ltd	10,509	$115.7K
Catalyst Funds Management Pty Ltd	3,700	$40.7K
Acadian Asset Management LLC	2,411	$26.0K
nVerses Capital, LLC	800	$8.81K

Not filed for Q4 2024 yet (1)

Institutions that held Astria Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding ATXS in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
ClariVest Asset Management LLC	80,315	$730.9K